VDR and chronic kidney disease: Second, VDR polymorphisms may affect CKD occurrence and development such as IgAN by inhibiting the anti-inflammatory activity of active vitamin D, protecting endothelial cells and promoting mesangial cell proliferation, podocyte loss, and tubulointerstitial fibrosis (Yang et al., 2012).